Evorel Sequi

Evorel Sequi Transdermal Patches 1x8 are indicated for hormone replacement therapy (HRT) for oestrogen deficiency symptoms in peri- and post-menopausal women.

Prevention of osteoporosis in postmenopausal women at high risk of future fractures who are intolerant of, or contraindicated for, other medicinal products approved for the prevention of osteoporosis.

Evorel Sequi is a transdermal therapy comprising:

a) Evorel 50 (4 Patches):

Each transdermal patch contains:

3.2 mg of estradiol hemihydrate equivalent to 3.1 mg estradiol

b) Evorel Conti (4 Patches):

Each transdermal patch contains:

3.2 mg of estradiol hemihydrate equivalent to 3.1 mg estradiol
11.2 mg of norethisterone acetate equivalent to 9.82 mg norethisterone

Available on request.

Available on request.